Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Swedish (OMX) Pharma Industry Analysis

UpdatedFeb 21, 2026
DataAggregated Company Financials
Companies23
  • 7D-2.7%
  • 3M-13.5%
  • 1Y-21.3%
  • YTD-14.7%

Over the last 7 days, the Pharma industry has dropped 2.7%, driven by a pullback from Camurus of 3.8%. However, the industry is down 21% over the past year. As for the next few years, earnings are expected to grow by 34% per annum.

Industry Valuation and Performance

Has the Swedish Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sat, 21 Feb 2026SEK 44.0bSEK 5.3b-SEK 1,345,581,873.0057.2x-32.7x8.3x
Mon, 19 Jan 2026SEK 54.0bSEK 5.3b-SEK 531,735,157.0071.9x-101.6x10.2x
Wed, 17 Dec 2025SEK 48.2bSEK 5.3b-SEK 531,735,157.0068.7x-90.7x9.1x
Fri, 14 Nov 2025SEK 50.4bSEK 5.3b-SEK 481,709,865.0068.6x-104.6x9.5x
Sun, 12 Oct 2025SEK 55.3bSEK 5.1b-SEK 405,183,865.0070.1x-136.5x10.9x
Tue, 09 Sep 2025SEK 58.6bSEK 5.1b-SEK 405,183,865.0079.9x-144.6x11.5x
Thu, 07 Aug 2025SEK 49.9bSEK 5.0b-SEK 45,588,364.0072.5x-1094.8x9.9x
Sat, 05 Jul 2025SEK 53.7bSEK 4.8b-SEK 525,205,364.0073.6x-102.3x11.2x
Mon, 02 Jun 2025SEK 44.9bSEK 4.8b-SEK 580,300,223.0561.9x-77.3x9.3x
Wed, 30 Apr 2025SEK 49.4bSEK 4.8b-SEK 917,663,156.0473x-53.8x10.4x
Fri, 28 Mar 2025SEK 49.7bSEK 4.7b-SEK 809,143,231.6171.6x-61.5x10.6x
Sun, 23 Feb 2025SEK 53.9bSEK 4.7b-SEK 753,905,705.9387.9x-71.5x11.5x
Tue, 21 Jan 2025SEK 50.1bSEK 4.4b-SEK 580,934,931.97125.5x-86.3x11.3x
Thu, 19 Dec 2024SEK 50.7bSEK 4.4b-SEK 615,780,894.31126.9x-82.3x11.4x
Sat, 16 Nov 2024SEK 52.2bSEK 4.4b-SEK 606,268,451.06125.9x-86.1x11.8x
Mon, 14 Oct 2024SEK 54.0bSEK 4.3b-SEK 676,771,483.54156.5x-79.8x12.6x
Wed, 11 Sep 2024SEK 68.8bSEK 5.9b-SEK 1,170,179,416.22182x-58.8x11.7x
Fri, 09 Aug 2024SEK 67.0bSEK 5.6b-SEK 992,683,437.4190.2x-67.5x12x
Sun, 07 Jul 2024SEK 67.3bSEK 6.4b-SEK 868,264,268.7377.6x-77.6x10.6x
Tue, 04 Jun 2024SEK 61.6bSEK 6.4b-SEK 766,337,474.2377.5x-80.4x9.7x
Thu, 02 May 2024SEK 49.7bSEK 6.3b-SEK 932,642,960.9266.5x-53.3x7.9x
Sat, 30 Mar 2024SEK 51.2bSEK 6.2b-SEK 1,038,134,430.6177.6x-49.4x8.2x
Mon, 26 Feb 2024SEK 46.9bSEK 6.2b-SEK 1,035,381,363.5583.2x-45.3x7.5x
Wed, 24 Jan 2024SEK 67.9bSEK 9.5b-SEK 1,182,181,896.0062x-57.4x7.2x
Fri, 22 Dec 2023SEK 66.8bSEK 9.4b-SEK 1,184,236,600.0061.6x-56.4x7.1x
Sun, 19 Nov 2023SEK 59.8bSEK 9.5b-SEK 1,172,208,091.0053.6x-51x6.3x
Tue, 17 Oct 2023SEK 51.2bSEK 9.2b-SEK 1,181,419,787.00104.9x-43.3x5.6x
Thu, 14 Sep 2023SEK 50.0bSEK 9.2b-SEK 1,177,942,693.00136x-42.4x5.4x
Sat, 12 Aug 2023SEK 52.4bSEK 8.9b-SEK 1,396,287,581.0086.2x-37.5x5.9x
Mon, 10 Jul 2023SEK 48.1bSEK 8.4b-SEK 1,693,591,395.0076.5x-28.4x5.8x
Wed, 07 Jun 2023SEK 47.5bSEK 8.4b-SEK 1,608,912,169.0076.7x-29.5x5.7x
Fri, 05 May 2023SEK 49.0bSEK 8.1b-SEK 1,815,501,123.0065.7x-27x6x
Sun, 02 Apr 2023SEK 45.4bSEK 8.0b-SEK 1,793,651,042.0089x-25.3x5.7x
Tue, 28 Feb 2023SEK 44.9bSEK 8.0b-SEK 1,783,453,638.00224.7x-25.2x5.6x
Price to Earnings Ratio

-25.2x


Total Market Cap: SEK 44.9bTotal Earnings: -SEK 1,783,453,638.00Total Revenue: SEK 8.0bTotal Market Cap vs Earnings and Revenue0%0%0%
Swedish Pharma Industry Price to Earnings3Y Average -73.4x202420252026
Current Industry PE
  • Investors are relatively neutral on the Swedish Pharmaceuticals industry at the moment, indicating that they anticipate long term growth rates to remain steady.
  • The industry is trading close to its 3-year average PS ratio of 9.0x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have improved over the last three years.
  • Meanwhile revenues for these companies have declined 13% per year.
  • This means that less sales are being generated overall, but since the cost of doing business is lower, losses have been shrinking.

Industry Trends

Which industries have driven the changes within the Swedish Healthcare industry?

SE Market1.64%
Healthcare0.85%
Pharma-2.73%
Pharma-2.73%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
KDV B KDventuresSEK 0.30-9.8%
SEK 105.5m		-71.1%PS116.4x
ENZY EnzymaticaSEK 1.9513.1%
+SEK 54.6m		20.1%PS8.8x
ANNX Annexin PharmaceuticalsSEK 19.8038.5%
+SEK 38.8m		-43.3%PB5.6x
SECARE SwedencareSEK 24.700.4%
+SEK 16.0m		-46.4%PE71.1x
CESSA CessatechDKK 19.402.3%
+DKK 8.2m		83.0%PB27.4x

Latest News

CAMX
SEK 532.50
Camurus
7D
-3.8%
1Y
-17.1%
CLBIO
SEK 14.70
Corline Biomedical
7D
-8.7%
1Y
46.3%
SECARE
SEK 24.70
Swedencare
7D
0.4%
1Y
-46.4%
ENZY
SEK 1.95
Enzymatica
7D
13.1%
1Y
20.1%
ANNX
SEK 19.80
Annexin Pharmaceuticals
7D
38.5%
1Y
-43.3%
MOB
SEK 9.40
Moberg Pharma
7D
2.5%
1Y
3.7%
ORX
SEK 26.90
Orexo
7D
-0.7%
1Y
57.7%
KDV B
SEK 0.30
KDventures
7D
-9.8%
1Y
-71.1%
CINPHA
SEK 17.54
Cinclus Pharma Holding
7D
1.3%
1Y
9.7%
IBT B
SEK 56.00
Infant Bacterial Therapeutics
7D
-0.7%
1Y
40.0%
ERMA
SEK 0.75
Enorama Pharma
7D
-29.0%
1Y
-65.9%
DICOT
SEK 0.30
Dicot Pharma
7D
-4.4%
1Y
14.9%

Is Dicot Pharma (STO:DICOT) In A Good Position To Invest In Growth?

Feb 03
Is Dicot Pharma (STO:DICOT) In A Good Position To Invest In Growth?
FLERIE
SEK 34.50
Flerie
7D
-0.1%
1Y
-26.9%
CESSA
DKK 19.40
Cessatech
7D
2.3%
1Y
83.0%
KLAR
SEK 0.76
Klaria Pharma Holding AB (publ.)
7D
-7.8%
1Y
-55.0%
GABA
SEK 0.028
Gabather
7D
-19.5%
1Y
-79.4%